---
figid: PMC3381956__nihms-381274-f0001
figtitle: Signaling pathways and their targeted therapies in NSCLC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3381956
filename: nihms-381274-f0001.jpg
figlink: /pmc/articles/PMC3381956/figure/F1/
number: F1
caption: Signaling pathways and their targeted therapies in NSCLC. Aberrant signaling
  resulting in activation of growth stimulatory pathways or interference of growth
  inhibitory pathways has been implicated in lung cancer pathogenesis. Activation
  of RTKs through ligand binding leads to up-regulation of multiple signaling pathways
  including the RAS/RAF/MEK pathway, the PI3K/AKT/mTOR pathway, and the STAT. GF,
  growth factor.
papertitle: Targeted Therapies for Lung Cancer.
reftext: Jill E. Larsen, et al. Cancer J. ;17(6):512-527.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9600943
figid_alias: PMC3381956__F1
figtype: Figure
redirect_from: /figures/PMC3381956__F1
ndex: aa2f90cc-decc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3381956__nihms-381274-f0001.html
  '@type': Dataset
  description: Signaling pathways and their targeted therapies in NSCLC. Aberrant
    signaling resulting in activation of growth stimulatory pathways or interference
    of growth inhibitory pathways has been implicated in lung cancer pathogenesis.
    Activation of RTKs through ligand binding leads to up-regulation of multiple signaling
    pathways including the RAS/RAF/MEK pathway, the PI3K/AKT/mTOR pathway, and the
    STAT. GF, growth factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - IGF1
  - TGFB1
  - TGFB2
  - TGFB3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - HGF
  - IL6
  - SOS1
  - EGF
  - EGFR
  - ERBB2
  - IGF1R
  - PDGFRB
  - PDGFRA
  - KIT
  - TNFSF10
  - PTEN
  - FADD
  - KRAS
  - HRAS
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TSC2
  - TSC1
  - CCL26
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MTOR
  - STK11
  - HIF1A
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
